American Journal of Transplantation

Papers
(The H4-Index of American Journal of Transplantation is 57. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Outside Front Cover303
Dissecting CMV latency and reactivation: BETing on the epigenetic regulators292
American Journal of Transplantation: Volume 21, Number 7, July 2021281
OFC 23rd Winter Symposium271
Navigating challenges in recipient selection for end-chain kidneys204
AJT Digest for Patients: Their Own Window into Key Research199
Dual Kidney Transplantation from Extended Marginal Donors in the United States: An analysis of SRTR and Literature Review191
Benefits Of Preemptive Transplantation In Older Patients with High KDPI Kidneys: Is Sooner Better Than Later?171
Disparities in liver transplantation: One size may not fit all138
Are we closer to abandoning protocol graft biopsies after pediatric liver transplantation?130
Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation?129
Optimization of donor flow matching and portal modulation to decrease small for size syndrome in Living Donor Liver Transplant - A Single Center American Experience122
Deceased Kidney Donors on Dialysis Create Opportunities for Renal Transplantation: A Single Center Experience118
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation113
Induction of fetomaternal tolerance? Suppressing B cells!111
Luminal polyethylene glycol solution delays the onset of preservation injury in the human intestine109
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report105
De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy104
Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates103
Pediatric cardiac xenotransplantation and stakeholder engagement101
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark100
International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation92
Phage-display immunoprecipitation for precision mapping the autoreactome92
Will the flu vaccine work this year?91
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients88
Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score86
Pure laparoscopic donor hepatectomy: Experience of 556 cases at Seoul National University Hospital81
Kaposi sarcoma herpesvirus inflammatory cytokine syndrome—a severe complication of an overlooked donor-derived infection79
OPTN/SRTR 2021 Annual Data Report: COVID-1978
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-1977
Accurate eplet identification is necessary for accurate risk assessment74
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study73
Microbiota and immunoregulation: A focus on regulatory B lymphocytes and transplantation73
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients72
Short- and long-term complications after living donor ileal resection72
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave70
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation66
Impact of interleukin-6 on T cells in kidney transplant recipients66
Alloantibodies after simultaneous liver-kidney transplant: A story of primary nonfunction, retransplantation, and antibody-mediated rejection66
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients66
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study65
Polymicrobial bacteremia in a heart transplant recipient: More than what meets the eye64
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-202064
An ethical analysis of conditional and partially directed live kidney donation among strangers—The Israeli experience64
Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report64
Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm63
The benefit to waitlist patients in a national paired kidney exchange program: Exploring characteristics of chain end living donor transplants62
Development of a natural language processing algorithm to extract social determinants of health from clinician notes62
First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient61
Rejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child61
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain61
New metrics to measure OPO performance are here: How do we ensure organizations receive feedback and improve organ donation?61
Long-term outcomes after normothermic machine perfusion in liver transplantation—Experience at a single North American center60
Dynamic impact of liver allocation policy change on donor utilization60
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation59
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study59
Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience58
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report57
0.11429500579834